Differential use of apolipoproteins and lipoproteins as discriminators for atherogenic risk
Mertz, D.P.; Göhmann, E.; Ostertag, J.
Die Medizinische Welt 32(43): 1611-1615
1981
ISSN/ISBN: 0025-8512 PMID: 7300661 Document Number: 171159
Document emailed within 1 workday
Related Documents
Pfalzer, B.; Hamm, H.; Beisiegel, U.; Ostendorf, P. 1992: Lipoproteins and apolipoproteins in human pleural effusions Journal of Laboratory and Clinical Medicine 120(3): 483-493de Arcos, F.; Castelo-Branco, C.; Casals, E.; Sanllehy, C.; Cararach, V. 1998: Normal and gestational diabetic pregnancies. Lipids, lipoproteins and apolipoproteins Journal of Reproductive Medicine 43(2): 144-148
Martseniuk, O.V.; Perova, N.V.; Misharin, A.I.; Antonov, I.V.; Kuznetsov, A.S. 1987: Interaction of plasma lipoproteins and apolipoproteins with lipid bilayer membranes Biofizika 32(2): 280-284
Gomo, Z.A. 1986: Concentrations of lipids, lipoproteins and apolipoproteins in Zimbabwean diabetic patients East African Medical Journal 63(8): 550-556
Lopukhin, I.M.; Andrianova, I.P.; Rabovskiĭ, A.B.; Nalivaĭko, E.S.; Kulaev, D.V. 1986: Affinity hemosorbent for the binding of atherogenic lipoproteins Kardiologiia 26(10): 54-57
Kafonek, S.D.; Derby, C.A.; Bachorik, P.S. 1992: Biological variability of lipoproteins and apolipoproteins in patients referred to a lipid clinic Clinical Chemistry 38(6): 864-872
Shinomiya, M.; Ishikawa, Y.; Shirai, K.; Saito, Y.; Yoshida, S. 1987: Effect of pirozadil on lipids, lipoproteins and apolipoproteins in Japanese with type IIa hyperlipoproteinemia Arzneimittel-Forschung 37(9): 1069-1071
Krawiec, A.; Cylwik, B.; Chrostek, L.; Supronowicz, Z.; Szmitkowski, M. 2008: The effect of chronic alcohol abuse on the lipids, lipoproteins and apolipoproteins concentrations in the sera Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 24(144): 521-525
Mainard, F.; Ozanne, P.; Madec, Y. 1982: Correlation of high-density lipoproteins with apolipoproteins a and B: selectivity criterion for three precipitation reagents Clinical Chemistry 28(4 Part 1): 729-730
Manabe, T.; Visvikis, S.; Dumon, M.F.; Clerc, M.; Siest, G. 1987: Evaluation of lipoproteins and apolipoproteins in serum of a Tangier patient by micro-scale two-dimensional electrophoresis Clinical Chemistry 33(4): 468-472
Gouache, P.; Le Moullac, B.; Bleiberg-Daniel, F.; Aubert, R.; Flament, C. 1991: Changes in rat plasma apolipoproteins and lipoproteins during moderate protein deficiency: potential use in the assessment of nutritional status Journal of Nutrition 121(5): 653-662
Torkhovskaia, T.I.; Khalilov, E.M.; Oleĭnik, I.A.; Kliuchnikova, Z.I.; Klimov, A.N. 1989: Changes in the levels and composition of lipoproteins and apolipoproteins of blood plasma in patients with ischemic heart disease after hemosorption Kardiologiia 29(10): 60-64
Zhu, T.; Wang, Z.; Zhao, S. 1998: Effect of apolipoprotein e gene plasma levels of lipids, lipoproteins, apolipoproteins and its relation with coronary heart disease Hunan Yi Ke da Xue Xue Bao 23(2): 149-151
Oyelola, O.O. 1993: Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives Contraception 47(5): 445-454
Mahley, R.W.; Weisgraber, K.H.; Innerarity, T.L.; Rall, S.C. 1991: Genetic defects in lipoprotein metabolism. Elevation of atherogenic lipoproteins caused by impaired catabolism JAMA 265(1): 78-83
Ahrén, T.; Lithell, H.; Victor, A.; Vessby, B.; Johansson, E.D. 1981: Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring. II. Serum lipoproteins and apolipoproteins Contraception 24(4): 451-468
Riesen, W.F.; Descoeudres, C.; Mordasini, R.; Girod, M.A. 1989: Selective elimination of atherogenic lipoproteins using dextran-sulfate cellulose. Experiences in 2 patients with heterozygote familial hypercholesterolemia Schweizerische Medizinische Wochenschrift 119(2): 55-58
Vasil'chenko, E.M.; Beĭko, V.A.; Tymchishin, P.N.; Karpov, R.S. 1989: Changes in the rosette-forming capacity of peripheral blood lymphocytes in patients with ischemic heart disease after administration of atherogenic lipoproteins Kardiologiia 29(2): 53-56
Vasil'chenko, E.M.; Beĭko, V.A.; Karpov, R.S.; Kanskaia, N.V. 1989: Characteristics of the action of modified atherogenic-class lipoproteins on the functional activity of peripheral blood lymphocytes in patients with ischemic heart disease Terapevticheskii Arkhiv 61(9): 56-59
Haarbo, J.; Hassager, C.; Jensen, S.B.; Riis, B.J.; Christiansen, C. 1991: Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives American Journal of Medicine 90(5): 584-589